Colgate Co Oh So Glowing

Stannous Fluoride


Colgate-palmolive Company
Human Otc Drug
NDC 35000-136
Colgate Co Oh So Glowing also known as Stannous Fluoride is a human otc drug labeled by 'Colgate-palmolive Company'. National Drug Code (NDC) number for Colgate Co Oh So Glowing is 35000-136. This drug is available in dosage form of Gel, Dentifrice. The names of the active, medicinal ingredients in Colgate Co Oh So Glowing drug includes Stannous Fluoride - 1.1 mg/g . The currest status of Colgate Co Oh So Glowing drug is Active.

Drug Information:

Drug NDC: 35000-136
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Colgate Co Oh So Glowing
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Stannous Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Colgate-palmolive Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Gel, Dentifrice
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:STANNOUS FLUORIDE - 1.1 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 10 Jan, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 31 Jan, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part355
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 07 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Colgate-Palmolive Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:416784
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:3FTR44B32Q
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
35000-136-681 TUBE in 1 CARTON (35000-136-68) / 99 g in 1 TUBE10 Jan, 202231 Jan, 2024No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purposes anticavity, antigingivitis, antisensitivity

Product Elements:

Colgate co oh so glowing stannous fluoride stannous fluoride fluoride ion sorbitol water hydrated silica polyethylene glycol 600 sodium lauryl sulfate sodium pyrophosphate potassium nitrate xanthan gum saccharin sodium cocamidopropyl betaine activated charcoal fd&c blue no. 1

Indications and Usage:

Uses aids in the prevention of cavities helps prevent gingivitis helps interfere with harmful effects of plaque associated with gingivitis builds increasing protection against painful sensitivity of the teeth to cold, heat, acid, sweets, or contact

Warnings:

Warnings when using this product for sensitivity, do not use longer than 4 weeks unless recommended by a dentist. stop use and ask a dentist if the sensitivity problem persists or worsens. sensitive teeth may indicate a serious problem that may need prompt care by a dentist. keep out of reach of children. if more than used for brushing is accidentally swallowed, get medical help or contact a poison control center right away. stop use and ask a dentist if gingivitis, bleeding or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth, or increasing space between the teeth. these may be signs of periodontis, a serious form of gum disease.

When Using:

When using this product for sensitivity, do not use longer than 4 weeks unless recommended by a dentist.

Dosage and Administration:

Directions adults and children 12 years of age and older: apply at least a 1-inch stip of the product onto a soft bristled toothbrush. brush teeth thoroughly for at least 1 minute twice a day (morning and evening) or as recommended by a dentist. make sure to brush all sensitive areas of the teeth. do not swallow. children under 12 years of age: consult a dentist.

Stop Use:

Stop use and ask a dentist if the sensitivity problem persists or worsens. sensitive teeth may indicate a serious problem that may need prompt care by a dentist.

Stop use and ask a dentist if gingivitis, bleeding or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth, or increasing space between the teeth. these may be signs of periodontis, a serious form of gum disease.

Package Label Principal Display Panel:

Principal display panel - 99 g tube carton co. by colgate ® oh so glowing gel toothpaste with charcoal gentle + effective whitening forever mint anticavity, antigingivitis and antisensitivity toothpaste net wt 3.5 oz (99 g) principal display panel - 99 g tube carton

Further Questions:

Questions? 1-855-658-0289


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.